Zusammenfassung
Die Blüten und das Kraut von Filipendula ulmaria (L.) Maxim. (Rosaceae; syn. Spirea ulmaria L.) sind Bestandteil der Phytotherapie Europas und werden als schweißtreibendes Mittel
bei Erkältungskrankheiten und bei geringfügigen Gelenkschmerzen eingesetzt. Sowohl
diese Anwendungen als auch die traditionelle Verwendung als harntreibendes Mittel
bzw. bei gastrointestinalen Beschwerden scheinen aufgrund der vorliegenden pharmakologischen
Studien plausibel. Die vorliegende Arbeit fasst den Stand der Forschung zu diesen
Arzneidrogen zusammen.
Summary
Meadowsweet
The flowers and the aerial parts from Filipendula ulmaria (L.) Maxim. (Rosaceae; syn. Spirea ulmaria L.) are an integral part in European phytotherapy and used as a diaphoretic in common
colds and for minor artricular pain. The use in these indications as well as in traditional
medicine as a diuretic and in gastrointestinal complaints seems plausible due to the
data from pharmacological research. This paper gives an overview over the state of
research on Filipendulae ulmariae herba and flos.
Schlüsselwörter
Filipendula ulmaria
- Botanik - Inhaltsstoffe - Pharmakologie - Übersicht
Key words
Filipendula ulmaria
- botany - chemistry - pharmacology - review
Literatur
- 1 Adler W. Oswald K. Fischer R. Exkursionsflora von Österreich. Stuttgart, Wien: Eugen
Ulmer; 1994
- 2 [Anonymous]. Filipendulae ulmeriae herba – Meadowsweet. ESCOP Monographs. 2nd ed.
Exeter: ESCOP; 2003: 157-161
- 3
Avdeeva EY.
Krasnov EA.
Shilova IV.
The composition of fraction from Filipendula ulmaria (L.) Maxim. possess expressed antioxidant activity.
Khimiya Rastitel’nogo Syr’ya.
2008;
(3)
115-118
- 4
Barnaulov OD.
Denisenko PP.
Antiulcerogenic action of the decoction from flowers of Filipendula ulmaria (L.) Maxim.
Pharmacol Toxicol.
1980;
43
700-705
- 5
Barnaulov OD.
Kumkov AV.
Khalikova NA.
et al..
Rastit Resur.
1977;
13
661-669
- 6
Barnaulov OD.
Manicheva OA.
Shelyuto Vl.
et al..
Effects of flavonoids on the development of experimental gastric dystrophies in mice.
Khim Farm Zh.
1984;
18
935-941
- 7
Bespalov VG.
Limarenko AY.
Voitenkov BL.
Anticarcinogenic, antitumor and modulating activities of dropwort Filipendula ulmaria flower decoction.
Khim Farm Zh.
1992;
26
59-61
- 8
Churin AA.
Masnaya NV.
Sherstoboev EY.
Shilova IV.
Effect of Filipendula ulmaria extract on immune system of CBA/CaLac and C57BL/6 mice.
Eksperimental’naya i Klinicheskaya Farmakologiya.
2008;
71
(5)
32-36
- 9
Csedö K.
Monea M.
Sabău Eşianu S.
The antibiotic activity of Filipendula ulmaria
.
Planta Med.
1993;
59
(Suppl.)
A675
- 10
Cwikla C.
Schmidt K.
Matthias A.
et al..
Investigations into the antibacterial activities of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni.
Phytother Res.
2010;
24
649-656
- 11
Fecka I.
Qualitative and quantitative determination of hydrolysable tannins and other polyphenols
in herbal products from meadowsweet and dog rose.
Phytochem Anal.
2009;
20
177-190
- 12
Halkes SBA.
Beukelman CJ.
Kroes BH.
et al..
In vitro immunomodulatory activity of Filipendula ulmaria
.
Phytother Res.
1997;
11
518-520
- 13
Halkes SBA.
Beukelman CJ.
Kroes BH.
et al..
A strong complement inhibitor from the flowers of Filipendula ulmaria (L.) Maxim.
Pharm Pharmacol Lett.
1997;
7
79-82
- 14
Kähkönen MP.
Hopia AI.
Vuorela HJ.
et al..
Antioxidant activity of plant extracts containing phenolic compounds.
J Agric Food Chem.
1999;
47
3954-3962
- 15
Kazazi F.
Halkes SBA.
Quarles van Ufford HC.
et al..
Inhibition of xanthine oxidase activity by Filipendula species.
Planta Med.
2009;
75
903
- 16
Krasnov EA.
Raldugin VA.
Avdeeva EY.
Medicinal plants – Filimarin, a new flavanol glycoside from Filipendula ulmaria and its antioxidant activity.
Pharm Chem J.
2009;
43
613-614
- 17
Kudryashov BA.
et al..
Heparin from Filipendula ulmaria and its properties.
Izv Akad Nauk SSSR, Ser Biol.
1991;
939-943
- 18
Kudryashov BA.
Lyapina LA.
Aziyeva LD.
Heparin-like anticoagulant content in Filipendula ulmaria flowers.
Farmakol Toksikol.
1990;
53
39-41
- 19
Lamaison JL.
Carnat A.
Petitjean-Freytet C.
Teneur en tanins et activité inhibitrice de l’élastase chez les Rosaceae.
Ann Pharm Franç.
1990;
48
335-340
- 20
Lamaison JL.
Petitjean-Freytet C.
Carnat A.
Teneurs en principaux flavonoides de parties aériennes Filipendula ulmaria (L.) Maxim. subsp. ulmaria et subsp. denudata (J. & C: Presl) Hayek.
Pharm Acta Helv.
1992;
67
218-222
- 21 Länger R. Schiller H. Gesundheit aus der Naturapotheke – Richtiger Umgang mit pflanzlichen
Arzneimitteln. Wien, New York: Springer; 2004
- 22
Liapina LA.
Koval’chuk GA.
A comparative study of the action on the hemostatic system of extracts from the flowers
and seeds of the meadowsweet (Filipendula ulmaria (L.) Maxim.)
Izvestiia Akademii nauk. Seriia biologicheskaia/Rossiiskaia akademiia nauk.
1993;
((4))
625-828
- 23
Lindeman A.
Jounela-Eriksson P.
Lounasmaa M.
The aroma composition of the flower of meadowsweet (Filipendula ulmaria (L.) Maxim.)
Lebensm Wiss Technol.
1982;
15
286-289
- 24
Manicheva OA.
Barnaulov OD.
Effect of plant drugs on the nucleic acid content of gastric tissues during ulcerogenesis.
Rastit Resur.
1984;
20
256-264
- 25
Mazzio EA.
Soliman KF.
In vitro screening for the tumoricidal properties of international medicinal herbs.
Phytother Res.
2009;
23
385-398
- 26 McGuffin M Hobbs C Upton R Goldberg A eds. Botanical Safety Handbook. Boca Raton:
CRC Press; 1997
- 27 Meier B. Meier-Liebi M Filipendula. In: Blaschek W Ebel S Hackenthal E Holzgrabe U
Keller K Reichling J Schulz V Hrsg. Hagers Enzyklopädie der Arzneistoffe und Drogen.
6. Aufl. Bd. 7. Stuttgart: Wiss Verlagsges; 2007
- 28 Mills S. Bone K. Principles and Practice of Phytotherapy. Edinburgh, New York,
Toronto: Churchill Livingstone; 2000
- 29
Molokovskii DS.
Davydov VV.
Khegai MD.
Antidiabetic activities of adaptogenic formulations and extns. from medicinal plants.
Rastit Resur.
2002;
38
((4))
15-28
- 30
Nesterova IV.
Povet’eva TN.
Aksinenko SG.
et al..
Evaluation of anti-inflammatory activity of extracts from Siberian plants.
Vestnik Rossiiskoi akademii meditsinskikh nauk/Rossiiskaia akademiia meditsinskikh
nauk.
2009;
((11))
30-34
- 31 Pahlow M. Das große Buch der Arzneipflanzen. München: Gräfe und Unzer; 1987
- 32
Papp I.
Apati P.
Andrasek V.
et al..
LC-MS analysis of antioxidant plant phenoloids.
Chromatographia.
2004;
60
S93-S100
- 33
Pashinskiy VG.
Aksinenko SG.
Gorbacheva AV.
et al..
Pharmacological activity and composition of extract from Filipendula ulmaria underground part.
Rastit Resur.
2006;
42
114-120
- 34
Pawlaczyk I.
Czerchawski L.
Pilecki W.
et al..
Polyphenolic-polysaccharide compounds from selected medicinal plants of Asteraceae
and Rosaceae families: Chemical characterization and blood anticoagulant activity.
Carbohydrate Polymers.
2009;
77
568-575
- 35
Peresunko AP.
Bespalov VG.
Limarenko AI.
Aleksandrov VA.
Clinico-experimental study of using plant preparations from the flowers of Filipendula ulmaria (L.) Maxim for the treatment of precancerous changes and prevention of uterine cervical
cancer.
Vopr Onkol.
1993;
39
291-295
- 36
Proestos C.
Boziaris IS.
Kapsokefalou M.
Komaitis M.
Natural antioxidant constituents from selected aromatic plants and their antimicrobial
activity against selected pathogenic microorganisms.
Food Technol Biotechnol.
2008;
46
151-156
- 37
Rauha JP.
Remes S.
Heinonen M.
et al..
Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic
compounds.
Int J Food Microbiol.
2000;
56
3-12
- 38
Šariæ-Kundaliæ B.
Dobeš C.
Klatte-Asselmeyer V.
Saukel J.
Ethnobotanical study on medicinal use of wild and cultivated plants in middle, south
and west Bosnia and Herzegovina.
J Ethnopharmacol.
2010;
131
33-55
- 39 Schilcher H. Kammerer S. Wegener T. Leitfaden Phytotherapie. 4. Aufl. München:
Urban & Fischer; 2010
- 40 Schneider W. Pflanzliche Drogen – Lexikon zur Arzneimittelgeschichte. Frankfurt:
Govi; 1974
- 41
Shilova IV.
Krasnov EA.
Korotkova EI.
et al..
Antioxidant properties of extracts from the above-ground parts of Filipendula ulmaria
.
Pharm Chem J.
2006;
40
660-662
- 42
Smolarz HD.
Sokolowska-Wozniak A.
Chromatographic analysis of phenolic acids in Filipendula ulmaria (L.) Maxim and Filipendula hexapetala Gilib.
Chem Environ Res.
2003;
12
77-82
- 43
Spiridonov NA.
Konovalov DA.
Arkhipov VV.
Cytotoxicity of some Russian ethnomedicinal plants and plant compounds.
Phytother Res.
2005;
19
428-432
- 44
Sroka Z.
Cisowski W.
Seredynska M.
Luczkiewicz M.
Phenolic extracts from meadowsweet and hawthorn flowers have antioxidative properties.
Z Naturforsch C.
2001;
56
739-744
- 45
Trouillas P.
Calliste CA.
Allais DP.
et al..
Antioxidant, anti-inflammatory and antiproliferative properties of sixteen water plant
extracts used in the Limousin countryside as herbal teas.
Food Chem.
2003;
80
399-407
- 46
Tunón H.
Olavsdotter C.
Bohlin L.
Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition
of prostaglandin biosynthesis and PAF-induced exocytosis.
J Ethnopharmacol.
1995;
48
61-76
- 47
Valle MG.
Nano GM.
Tira S.
Das ätherische Öl von Filipendula ulmaria
.
Planta Med.
1988;
54
181-182
- 48 Wichtl M. Loew D. Filipendulae ulmaria herba. In: Wichtl M Hrsg. Teedrogen und
Phytopharmaka. 5. Aufl.. Stuttgart: Wiss Verlagsges; 2009
- 49
Wilkes S.
Glasl H.
Isolation, characterization, and systematic significance of 2-pyrone-4,6-dicarboxylic
acid in Rosaceae.
Phytochemistry.
2001;
58
441-449
Ao. Univ.-Prof. Dr. Liselotte Krenn
Department für Pharmakognosie
Universität Wien
Althanstr. 14
A-1090 Wien
Österreich
eMail: liselotte.krenn@univie.ac.at
